Research & Development
The Progel® technology platform provides engineers and chemists at Neomend, Inc. an ideal foundation for the development of new, unique products designed to accommodate the most cutting-edge surgical procedures. The patented Progel formulation utilizes a proprietary binding mechanism to combine a large biocompatible protein with a functionalized polyethylene glycol molecule. The result is a robust polymer hydrogel with a physical and chemical structure that can be controlled and adapted to perform according to very specific clinical specifications and requirements.
Examples of some of the primary research and development initiatives currently underway at Neomend, Inc. include:
Progel® Adhesion Barrier Sealant
Progel® Dural Sealant
For a list of Neomend, Inc. products currently available outside the US, please visit our International Products.
For full prescribing information, including indications, effects, routes, methods, frequency and duration of administration and any relevant hazards, contraindications, side effects, and precautions, please review the Instructions for Use.